This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
6,955 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
A quiet market signal could hint at trouble ahead. This article explains what the under-the-radar index signaling mea...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
A new wave of traditional finance players is building on Solana to streamline crypto payments and cross-border transf...
When markets tank, investors ask which asset holds up better. This article compares XRP and Shiba Inu to help you dec...
QVC is leaning into TikTok's live shopping fever as traditional TV fades. The move aims to spark a new growth engine ...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
SMCI stock rose roughly 5% on Monday after last week's 33% rout, as federal charges against a co-founder sharpen gove...